Drugs / Fluticasone/Salmeterol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00829257 Background | Jan 2009 → Jul 2010 | asthma | University of Dundee | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2018-09-10 | Glenmark Pharmaceuticals Ltd. India | Glenmark secures marketing authorization in Germany for its generic version of Seretide® Accuhaler® glenmarkpharma.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluticasone/Salmeterol | “Fluticasone/Salmeterol (Seretide) 500/50ug, 1 puff b.i.d” NCT00829257 ↗ |
| Known as | Seretide | “Fluticasone/Salmeterol (Seretide) 500/50ug, 1 puff b.i.d” NCT00829257 ↗ |